NA-001 (Allero Therapeutics)

N/A

Report date: 2024/01/24 15:07:22
NME

Base Information

Drug NameNA-001 (Allero Therapeutics)
Drug Alias NameN/A
ClassificationOther
Mechanisms of ActionT-cell receptor agonists
TargetsT-cell receptor
Therapy Area/IndicationsAdenosine deaminase deficiency
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryNetherlands
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesAllero Therapeutics BV
China Registration ClassN/A

Develop Information

Active CompaniesAllero Therapeutics BV
Inactive CompaniesN/A
Active IndicationsAdenosine deaminase deficiency
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A